** Shares of Mach7 Technologies M7T.AX extend gains from the previous session to climb 8% to A$0.4
** Stock hits highest level since Nov 5, 2024
** The medical imaging systems provider posts contracted annual recurring revenue $(CARR)$ of A$31.8 mln ($19.76 mln) at Dec 31, up 15.6% from Sept 2024 levels
** Co reaffirms FY25 outlook for 15-25% growth in CARR
** Co announced on-market buyback programme of up to A$5 mln on Thursday
** About 1.1 mln shares change hands, 2.5 times the 30-day average of share
** Stock down 7.5% this year, as of last close
($1 = 1.6095 Australian dollars)
(Reporting by Sherin Sunny in Bengaluru)
((Sherin.Sunny@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。